Skip to main content
. 2012 May 21;30(19):2401–2407. doi: 10.1200/JCO.2011.39.9394

Table A9.

Comparison of Clinical Benefit Rate by Genotype

Genotype Clinical Benefit
No. % 95% CI
Exon 9 (n = 3) 2 66.7 9.4 to 99.2
Exon 11 (n = 19) 16 84.2 60.4 to 96.6
Wild type (n = 8) 6 75.0 34.9 to 96.8

NOTE. There was no statistically significant difference in clinical benefit rate in different GI stromal tumor genotype groups using Fisher's exact test.